Retatrutide is a newly developed therapy that acts as a powerful GLP-1 receptor stimulator. This breakthrough approach holds significant hope for regulating type 2 diabetes. By mimicking the actions of natural GLP-1, Retatrutide enhances insulin secretion and suppresses glucagon release, leading to improved blood sugar control. Clinical trials have